ReKlame aims to provide mental health services to Black patients and historically underserved communities, according to an April 12 news release announcing the launch. The program is currently treating patients with alcohol use disorder in the BIPOC community in New York City.
The program starts patients with Naltrexone, an oral medication that blocks brain receptors and fights cravings associated with alcohol and opioid use, paired with tele-psychiatry appointments.
After a patient’s medication tolerance is assessed, their ReKlame provider will eventually send a nurse to the patient’s home to administer a monthly shot of Naltrexone LAI, according to the release.
